KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Gains from Investment Securities: 2011-2015

Historic Gains from Investment Securities for Biocryst Pharmaceuticals (BCRX) over the last 3 years, with Sep 2015 value amounting to $9.8 million.

  • Biocryst Pharmaceuticals' Gains from Investment Securities rose 17.34% to $9.8 million in Q3 2015 from the same period last year, while for Sep 2015 it was $9.8 million, marking a year-over-year increase of 17.34%. This contributed to the annual value of $7.5 million for FY2024, which is 246.92% up from last year.
  • As of Q3 2015, Biocryst Pharmaceuticals' Gains from Investment Securities stood at $9.8 million, which was up 0.15% from $9.8 million recorded in Q2 2015.
  • Over the past 5 years, Biocryst Pharmaceuticals' Gains from Investment Securities peaked at $10.3 million during Q1 2015, and registered a low of $7.9 million during Q4 2011.
  • For the 3-year period, Biocryst Pharmaceuticals' Gains from Investment Securities averaged around $9.2 million, with its median value being $9.1 million (2013).
  • Per our database at Business Quant, Biocryst Pharmaceuticals' Gains from Investment Securities fell by 8.52% in 2014 and then rose by 20.00% in 2015.
  • Quarterly analysis of 5 years shows Biocryst Pharmaceuticals' Gains from Investment Securities stood at $7.9 million in 2011, then grew by 2.74% to $8.1 million in 2012, then climbed by 11.31% to $9.0 million in 2013, then increased by 6.89% to $9.6 million in 2014, then grew by 17.34% to $9.8 million in 2015.
  • Its last three reported values are $9.8 million in Q3 2015, $9.8 million for Q2 2015, and $10.3 million during Q1 2015.